Galmed Pharmaceuticals
GLMD
GLMD
26 hedge funds and large institutions have $11.8M invested in Galmed Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
19% less capital invested
Capital invested by funds: $14.6M → $11.8M (-$2.83M)
84% less call options, than puts
Call options by funds: $80K | Put options by funds: $504K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
26
Holding in Top 10
–
Calls
$80K
Puts
$504K
Top Buyers
| 1 | +$69K | |
| 2 | +$60.8K | |
| 3 | +$58K | |
| 4 |
Millennium Management
New York
|
+$36K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$19.9K |
Top Sellers
| 1 | -$1.59M | |
| 2 | -$77.3K | |
| 3 | -$54.7K | |
| 4 |
JF
Jump Financial
Chicago,
Illinois
|
-$51K |
| 5 |
Two Sigma Advisers
New York
|
-$46K |